Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Trial of Perioperative Endocrine Therapy - Individualising Care 01/14/2015 INTERVENTIONAL not-comparable 4,287.75 0 Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy 01/15/2015 INTERVENTIONAL not-comparable 4,286.75 0 Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer 01/26/2015 INTERVENTIONAL not-comparable 4,275.75 0 A Trial of Vigil for Participants With Ovarian Cancer 01/27/2015 INTERVENTIONAL not-comparable 4,274.75 0 MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ 02/02/2015 INTERVENTIONAL not-comparable 4,268.75 0 GnRH for Luteal Support in IVF/ICSI/FET Cycles 02/06/2015 INTERVENTIONAL not-comparable 4,264.75 0 Assessing the Impact of Contraceptives on Bone Health Using 41Ca 02/20/2015 INTERVENTIONAL not-comparable 4,250.75 0 Node Negative, Invasive Breast Cancer Single Fraction IOERT 02/25/2015 INTERVENTIONAL not-comparable 4,245.75 0 Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression 02/27/2015 OBSERVATIONAL not-comparable 4,243.75 0 Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study 03/04/2015 INTERVENTIONAL not-comparable 4,238.75 0 Longitudinal Study of Intra-Uterine Growth Restriction 03/09/2015 OBSERVATIONAL not-comparable 4,233.75 0 Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost 03/10/2015 INTERVENTIONAL not-comparable 4,232.75 0 Effects of High Altitude on AMPK Activation 03/18/2015 OBSERVATIONAL not-comparable 4,224.75 0 Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) 03/19/2015 INTERVENTIONAL not-comparable 4,223.75 0 Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer 03/24/2015 INTERVENTIONAL not-comparable 4,218.75 0 The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) 03/26/2015 INTERVENTIONAL not-comparable 4,216.75 0 Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer 03/27/2015 INTERVENTIONAL not-comparable 4,215.75 0 POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer 03/30/2015 INTERVENTIONAL not-comparable 4,212.75 0 Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP) 04/09/2015 INTERVENTIONAL not-comparable 4,202.75 0 Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy 04/21/2015 INTERVENTIONAL not-comparable 4,190.75 0 Cyrolipolysis vs Cyrolipolysis and Subcision for Cellulite 04/28/2015 INTERVENTIONAL not-comparable 4,183.75 0 TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors 04/29/2015 INTERVENTIONAL not-comparable 4,182.75 0 TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors 04/29/2015 INTERVENTIONAL not-comparable 4,182.75 0 Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients 04/30/2015 OBSERVATIONAL not-comparable 4,181.75 0 Safety and Durability of Sirolimus for Treatment of LAM 05/04/2015 OBSERVATIONAL not-comparable 4,177.75 0 Vitamin D and Angiogenic Markers in Odense Child Cohort 1 05/06/2015 OBSERVATIONAL not-comparable 4,175.75 0 Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab 05/07/2015 INTERVENTIONAL not-comparable 4,174.75 0 Placental Passage and Disposition of Drugs: A Physiology-based Approach 05/08/2015 OBSERVATIONAL not-comparable 4,173.75 0 The Vitamin D and Fetal Bone Length Study (VITFBL) 05/08/2015 OBSERVATIONAL not-comparable 4,173.75 0 Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer 05/18/2015 INTERVENTIONAL not-comparable 4,163.75 0 Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer 05/27/2015 INTERVENTIONAL not-comparable 4,154.75 0 Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery 05/28/2015 INTERVENTIONAL not-comparable 4,153.75 0 Infant Microbiota and Probiotic Intake Study 05/29/2015 INTERVENTIONAL not-comparable 4,152.75 0 Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI 06/04/2015 OBSERVATIONAL not-comparable 4,146.75 0 Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery 06/09/2015 INTERVENTIONAL not-comparable 4,141.75 0 Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers 06/09/2015 INTERVENTIONAL not-comparable 4,141.75 0 Ovarian Reserve After Cancer: Longitudinal Effects 06/09/2015 OBSERVATIONAL not-comparable 4,141.75 0 Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates 06/15/2015 OBSERVATIONAL not-comparable 4,135.75 0 Laparoscopic Surgery for Severe Recto-vaginal Endometriosis 06/15/2015 OBSERVATIONAL not-comparable 4,135.75 0 Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer 06/18/2015 INTERVENTIONAL not-comparable 4,132.75 0 Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score 06/19/2015 INTERVENTIONAL not-comparable 4,131.75 0 Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer 06/26/2015 INTERVENTIONAL not-comparable 4,124.75 0 The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer 06/30/2015 INTERVENTIONAL not-comparable 4,120.75 0 Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma 07/01/2015 INTERVENTIONAL not-comparable 4,119.75 0 A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer 07/02/2015 INTERVENTIONAL not-comparable 4,118.75 0 Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer 07/07/2015 INTERVENTIONAL not-comparable 4,113.75 0 A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma 07/07/2015 INTERVENTIONAL not-comparable 4,113.75 0 Management of Low-risk (Grade I and II) DCIS 07/08/2015 INTERVENTIONAL not-comparable 4,112.75 0 Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer 07/10/2015 INTERVENTIONAL not-comparable 4,110.75 0 White Adipose Tissue in Pregnancy Study 07/14/2015 OBSERVATIONAL not-comparable 4,106.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology